Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment
Crossref DOI link: https://doi.org/10.1007/s00259-015-3189-0
Published Online: 2015-09-18
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bombardieri, Emilio
Evangelista, L.
Ceresoli, G. L.
Boccardo, F.
Text and Data Mining valid from 2015-09-18